GLAXOSMITHKLINE FDA Approval ANDA 075822

ANDA 075822

GLAXOSMITHKLINE

FDA Drug Application

Application #075822

Documents

Review2007-05-09
Letter2003-02-10

Application Sponsors

ANDA 075822GLAXOSMITHKLINE

Marketing Status

Over-the-counter001

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL10MG0LORATADINELORATADINE

FDA Submissions

ORIG1AP2003-02-10
LABELING; LabelingSUPPL2AP2008-01-25

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75822
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"LORATADINE","activeIngredients":"LORATADINE","strength":"10MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LORATADINE","submission":"LORATADINE","actionType":"10MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.